{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:47:35Z","timestamp":1777628855913,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Research Project of Guangdong Provincial Bureau of Traditional Chinese Medicine","award":["20231159"],"award-info":[{"award-number":["20231159"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08010-7","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:24:28Z","timestamp":1774009468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A machine learning-based epigenetic signature reveals YTHDC1 stabilizes POU5F1 to oppose tumor progression"],"prefix":"10.1186","volume":"24","author":[{"given":"Chen","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diamond","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangling","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"3","key":"8010_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"8010_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-019-0669-z","volume":"11","author":"JJ de Jong","year":"2019","unstructured":"de Jong JJ, Liu Y, Robertson AG, Seiler R, Groeneveld CS, van der Heijden MS, Wright JL, Douglas J, Dall\u2019Era M, Crabb SJ, et al. Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis. Genome Med. 2019;11(1):60.","journal-title":"Genome Med"},{"issue":"1","key":"8010_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comp\u00e9rat EM, Cowan NC, Gakis G, Hern\u00e1ndez V, Linares Espin\u00f3s E, Lorch A, Neuzillet Y, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol. 2021;79(1):82\u2013104.","journal-title":"Eur Urol"},{"issue":"8","key":"8010_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","volume":"20","author":"TW Flaig","year":"2022","unstructured":"Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, et al. NCCN Guidelines\u00ae Insights: Bladder Cancer, Version 2.2022. J Natl Compr Canc Netw. 2022;20(8):866\u201378.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"8010_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"8010_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/15384101.2022.2154551","volume":"22","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liu J, Yang X, Jiao W, Shen C, Zhao X, Wang Y. High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer. Cell Cycle. 2023;22(5):610\u20138.","journal-title":"Cell Cycle"},{"key":"8010_CR7","doi-asserted-by":"crossref","unstructured":"Chen Y, Jiao W, Wang Y, Liang Z, Wang L, Li D, Liang Y, Niu H. Microtubule interacting and trafficking domain containing 1 deficiency leads to poor survival via tissue factor-mediated coagulation in bladder cancer. J Thromb Haemost. 2024.","DOI":"10.1016\/j.jtha.2024.03.015"},{"issue":"1","key":"8010_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13046-023-02860-5","volume":"42","author":"WM Hu","year":"2023","unstructured":"Hu WM, Li M, Ning JZ, Tang YQ, Song TB, Li LZ, Zou F, Cheng F, Yu WM. FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression. J Exp Clin Cancer Res. 2023;42(1):290.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"8010_CR9","doi-asserted-by":"publisher","first-page":"e110620","DOI":"10.15252\/embj.2022110620","volume":"42","author":"K Shigeta","year":"2023","unstructured":"Shigeta K, Hasegawa M, Hishiki T, Naito Y, Baba Y, Mikami S, Matsumoto K, Mizuno R, Miyajima A, Kikuchi E, et al. IDH2 stabilizes HIF-1\u03b1-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. Embo j. 2023;42(4):e110620.","journal-title":"Embo j"},{"issue":"24","key":"8010_CR10","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","volume":"70","author":"S Roessler","year":"2010","unstructured":"Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 2010;70(24):10202\u201312.","journal-title":"Cancer Res"},{"issue":"7","key":"8010_CR11","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s12094-022-02782-2","volume":"24","author":"Z Wang","year":"2022","unstructured":"Wang Z, Zhang Y, Jiang C, Gong B. A novel immune-related RNA-binding proteins signature to predict survival and therapeutic responses in prostate cancer. Clin Transl Oncol. 2022;24(7):1381\u201394.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"8010_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12967-022-03656-5","volume":"20","author":"R Zhang","year":"2022","unstructured":"Zhang R, Liu F. Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients. J Transl Med. 2022;20(1):453.","journal-title":"J Transl Med"},{"issue":"1","key":"8010_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-016-0544-0","volume":"15","author":"X Zhu","year":"2016","unstructured":"Zhu X, Tian X, Yu C, Shen C, Yan T, Hong J, Wang Z, Fang JY, Chen H. A long non-coding RNA signature to improve prognosis prediction of gastric cancer. Mol Cancer. 2016;15(1):60.","journal-title":"Mol Cancer"},{"issue":"2","key":"8010_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2217\/fon-2018-0221","volume":"15","author":"M Brand\u00e3o","year":"2019","unstructured":"Brand\u00e3o M, Pond\u00e9 N, Piccart-Gebhart M. Mammaprint\u2122: a comprehensive review. Future Oncol. 2019;15(2):207\u201324.","journal-title":"Future Oncol"},{"issue":"8","key":"8010_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso F, van\u2019t Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, DeLorenzi M, et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. N Engl J Med. 2016;375(8):717\u201329.","journal-title":"N Engl J Med"},{"key":"8010_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejca.2021.06.032","volume":"154","author":"MG Davey","year":"2021","unstructured":"Davey MG, Richard V, Lowery AJ, Kerin MJ. OncotypeDX\u00a9 Recurrence Score in BRCA mutation carriers: a systematic review and meta-analysis. Eur J Cancer. 2021;154:209\u201316.","journal-title":"Eur J Cancer"},{"issue":"2","key":"8010_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.14740\/wjon1019w","volume":"8","author":"L Xin","year":"2017","unstructured":"Xin L, Liu YH, Martin TA, Jiang WG. The Era of Multigene Panels Comes? The Clinical Utility of Oncotype DX and MammaPrint. World J Oncol. 2017;8(2):34\u201340.","journal-title":"World J Oncol"},{"issue":"9","key":"8010_CR18","doi-asserted-by":"publisher","first-page":"107722","DOI":"10.1016\/j.isci.2023.107722","volume":"26","author":"Y Qin","year":"2023","unstructured":"Qin Y, Zu X, Li Y, Han Y, Tan J, Cai C, Shen E, Liu P, Deng G, Feng Z, et al. A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer. iScience. 2023;26(9):107722.","journal-title":"iScience"},{"issue":"Pt A","key":"8010_CR19","doi-asserted-by":"publisher","first-page":"106186","DOI":"10.1016\/j.compbiomed.2022.106186","volume":"151","author":"J Cheng","year":"2022","unstructured":"Cheng J, Zhang S, Fan A, Li Y, Xu P, Huang J, He M, Wang H. An immune-related gene signature for the prognosis of human bladder cancer based on WGCNA. Comput Biol Med. 2022;151(Pt A):106186.","journal-title":"Comput Biol Med"},{"key":"8010_CR20","doi-asserted-by":"crossref","unstructured":"Xu X, Tian X, Song L, Xie J, Liao JC, Meeks JJ, Wu XR, Gin GE, Wang B, Uchio E, et al. Kawain Inhibits Urinary Bladder Carcinogenesis through Epigenetic Inhibition of LSD1 and Upregulation of H3K4 Methylation. Biomolecules. 2023;13(3).","DOI":"10.3390\/biom13030521"},{"key":"8010_CR21","doi-asserted-by":"crossref","unstructured":"Monteiro-Reis S, Lobo J, Henrique R, Jer\u00f3nimo C. Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer. Int J Mol Sci. 2019;20(2).","DOI":"10.3390\/ijms20020297"},{"key":"8010_CR22","doi-asserted-by":"crossref","unstructured":"Gilyazova I, Enikeeva K, Rafikova G, Kagirova E, Sharifyanova Y, Asadullina D, Pavlov V. Epigenetic and Immunological Features of Bladder Cancer. Int J Mol Sci. 2023;24(12).","DOI":"10.3390\/ijms24129854"},{"key":"8010_CR23","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, Mo Q, Zhao X, Fan Q, Deng F, et al. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat. 2023;68:100938.","journal-title":"Drug Resist Updat"},{"issue":"11","key":"8010_CR24","doi-asserted-by":"publisher","first-page":"8714","DOI":"10.1002\/jcp.29715","volume":"235","author":"D Luo","year":"2020","unstructured":"Luo D, Liu Q, Shan Z, Cai S, Li Q, Li X. Development and validation of a novel epigenetic signature for predicting prognosis in colon cancer. J Cell Physiol. 2020;235(11):8714\u201323.","journal-title":"J Cell Physiol"},{"issue":"1","key":"8010_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12935-024-03447-6","volume":"24","author":"X Liu","year":"2024","unstructured":"Liu X, Chen C, Li J, Li L, Ma M. Identification of tumor-specific T cell signature predicting cancer immunotherapy response in bladder cancer by multi-omics analysis and experimental verification. Cancer Cell Int. 2024;24(1):255.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"8010_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"8010_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"7693","key":"8010_CR28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"5","key":"8010_CR29","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-11-2271","volume":"18","author":"M Riester","year":"2012","unstructured":"Riester M, Taylor JM, Feifer A, Koppie T, Rosenberg JE, Downey RJ, Bochner BH, Michor F. Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin Cancer Res. 2012;18(5):1323\u201333.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"8010_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25(2):152\u201365.","journal-title":"Cancer Cell"},{"issue":"6","key":"8010_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"1","key":"8010_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"issue":"5","key":"8010_CR33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"W1","key":"8010_CR34","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","journal-title":"Nucleic Acids Res"},{"key":"8010_CR35","doi-asserted-by":"crossref","unstructured":"Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017;6.","DOI":"10.7554\/eLife.26476"},{"issue":"1","key":"8010_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, Krogsdam A, Loncova Z, Posch W, Wilflingseder D, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11(1):34.","journal-title":"Genome Med"},{"issue":"19","key":"8010_CR37","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/bioinformatics\/btw325","volume":"32","author":"ZL Skidmore","year":"2016","unstructured":"Skidmore ZL, Wagner AH, Lesurf R, Campbell KM, Kunisaki J, Griffith OL, Griffith M. GenVisR: Genomic Visualizations in R. Bioinformatics. 2016;32(19):3012\u20134.","journal-title":"Bioinformatics"},{"issue":"7","key":"8010_CR38","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W. Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"8010_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"1","key":"8010_CR40","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y, Hu J, Chen K. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020;11(1):5077.","journal-title":"Nat Commun"},{"key":"8010_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1755-8794-3-21","volume":"3","author":"A Gribov","year":"2010","unstructured":"Gribov A, Sill M, L\u00fcck S, R\u00fccker F, D\u00f6hner K, Bullinger L, Benner A, Unwin A. SEURAT: visual analytics for the integrated analysis of microarray data. BMC Med Genomics. 2010;3:21.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"8010_CR42","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"key":"8010_CR43","doi-asserted-by":"crossref","unstructured":"Wu Z, Wang W, Zhang K, Fan M, Lin R. Epigenetic and Tumor Microenvironment for Prognosis of Patients with Gastric Cancer. Biomolecules. 2023;13(5).","DOI":"10.3390\/biom13050736"},{"key":"8010_CR44","doi-asserted-by":"publisher","first-page":"117955492312031","DOI":"10.1177\/11795549231203150","volume":"17","author":"L Zhao","year":"2023","unstructured":"Zhao L, Han D, Zhu J, Bi D, Ding T, Zhu X, Huang D, Zhang Y, Lu L, Wu W, et al. The RNA m6A-Binding Protein YTHDC1 Is Downregulated and Associated With M2 Macrophage Infiltration in Muscle-Invasive Bladder Cancer. Clin Med Insights Oncol. 2023;17:11795549231203150.","journal-title":"Clin Med Insights Oncol"},{"issue":"7","key":"8010_CR45","doi-asserted-by":"publisher","first-page":"e13404","DOI":"10.1111\/cpr.13404","volume":"56","author":"Y Su","year":"2023","unstructured":"Su Y, Wang B, Huang J, Huang M, Lin T. YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer. Cell Prolif. 2023;56(7):e13404.","journal-title":"Cell Prolif"},{"issue":"9","key":"8010_CR46","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/s41416-023-02195-0","volume":"128","author":"YC Tsai","year":"2023","unstructured":"Tsai YC, Wang TY, Hsu CL, Lin WC, Chen JY, Li JH, Pu YS, Cheng AL, Cheng JC, Su SF. Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling. Br J Cancer. 2023;128(9):1753\u201364.","journal-title":"Br J Cancer"},{"issue":"1","key":"8010_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10565-024-09859-4","volume":"40","author":"D Dong","year":"2024","unstructured":"Dong D, Wei J, Wang W, Zhou H, Hong L, Ji G, Yang X. YTHDC1 promotes the malignant progression of gastric cancer by promoting ROD1 translocation to the nucleus. Cell Biol Toxicol. 2024;40(1):19.","journal-title":"Cell Biol Toxicol"},{"issue":"14","key":"8010_CR48","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1016\/j.molcel.2025.06.017","volume":"85","author":"C Dai","year":"2025","unstructured":"Dai C, Tang Y, Yang H, Zheng J. YTHDC1 lactylation regulates its phase separation to enhance target mRNA stability and promote RCC progression. Mol Cell. 2025;85(14):2733\u2013e27482737.","journal-title":"Mol Cell"},{"issue":"4","key":"8010_CR49","doi-asserted-by":"publisher","first-page":"115545","DOI":"10.1016\/j.celrep.2025.115545","volume":"44","author":"Z Xing","year":"2025","unstructured":"Xing Z, Yang T, Li X, Xu H, Hong Y, Shao S, Li T, Ye L, Li Y, Jin X, et al. High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy. Cell Rep. 2025;44(4):115545.","journal-title":"Cell Rep"},{"issue":"6","key":"8010_CR50","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s12276-023-00997-z","volume":"55","author":"B Yan","year":"2023","unstructured":"Yan B, Li X, Peng M, Zuo Y, Wang Y, Liu P, Ren W, Jin X. The YTHDC1\/GLUT3\/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression. Exp Mol Med. 2023;55(6):1145\u201358.","journal-title":"Exp Mol Med"},{"issue":"1","key":"8010_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41419-025-07545-9","volume":"16","author":"N Sun","year":"2025","unstructured":"Sun N, Wang S, Liu J, Zhang P, Chang Y, Li H, Zhao K, Liu Y, Huang M, Hu Y, et al. XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1. Cell Death Dis. 2025;16(1):205.","journal-title":"Cell Death Dis"},{"issue":"1","key":"8010_CR52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s12276-024-01377-x","volume":"57","author":"J Xu","year":"2025","unstructured":"Xu J, Koch J, Schmidt C, Nientiedt M, Neuberger M, Erben P, Michel MS, Rodr\u00edguez-Paredes M, Lyko F. Loss of YTHDC1 m(6)A reading function promotes invasiveness in urothelial carcinoma of the bladder. Exp Mol Med. 2025;57(1):118\u201330.","journal-title":"Exp Mol Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08010-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08010-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08010-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:02:39Z","timestamp":1777428159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08010-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8010"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08010-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics declaration and consent to participate: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"608"}}